The popularity of copyright’s blockbuster initially drove a period of growth for the drug industry, however recent developments present a murky outlook for shareholders. Generic versions are reducing earnings, and https://neveocme651883.timeblog.net/77068311/the-blue-pill-and-the-pharmaceutical-industry-a-risky-investment